Cargando…
Time-varying SUVr reflects the dynamics of dopamine increases during methylphenidate challenges in humans
Dopamine facilitates cognition and is implicated in reward processing. Methylphenidate, a dopamine transporter blocker widely used to treat attention-deficit/hyperactivity disorder, can have rewarding and addictive effects if injected. Since methylphenidate’s brain uptake is much faster after intrav...
Autores principales: | Tomasi, Dardo, Manza, Peter, Logan, Jean, Shokri-Kojori, Ehsan, Yonga, Michele-Vera, Kroll, Danielle, Feldman, Dana, McPherson, Katherine, Biesecker, Catherine, Dennis, Evan, Johnson, Allison, Yuan, Kai, Wang, Wen-Tung, Butman, John A., Wang, Gene-Jack, Volkow, Nora D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918528/ https://www.ncbi.nlm.nih.gov/pubmed/36765261 http://dx.doi.org/10.1038/s42003-023-04545-3 |
Ejemplares similares
-
Sex differences in methylphenidate-induced dopamine increases in ventral striatum
por: Manza, Peter, et al.
Publicado: (2021) -
Neural circuit selective for fast but not slow dopamine increases in drug reward
por: Manza, Peter, et al.
Publicado: (2023) -
Cortical D1 and D2 dopamine receptor availability modulate methylphenidate-induced changes in brain activity and functional connectivity
por: Manza, Peter, et al.
Publicado: (2022) -
Striatal D1 and D2 receptor availability are selectively associated with eye-blink rates after methylphenidate treatment
por: Demiral, Şükrü B., et al.
Publicado: (2022) -
Sleep disturbances are associated with cortical and subcortical atrophy in alcohol use disorder
por: Zhang, Rui, et al.
Publicado: (2021)